It is a RTO but I cannot remember the original code. I'm not...

It is a RTO but I cannot remember the original code. I'm not familiar with it but I make a point of remembering Anton's calls.
RAC may interest you also. I'm holding it. Recent listing. It's edge is it has low EV for a company with a drug that's had millions previously invested in its research. A cancer treatment that is already approved in France. So probably early revenue as they seek future FDA approval. They found the 'lost' drug bisantrene that fell between the cracks during some previous company mergers. Kind of a unique prospect I feel.